In particular, the inhibitory effect of the Rev-Erba agonist was almost abolished in DDIT4-knockout cells (Fig. 6G), indicating that the greatest fold changes in DDIT4 expression caused by the Rev-Erba agonist may be the factor that most strongly contributes to its inhibitory effect on osteosarcoma growth. This evidence concerns the gene DDIT4 and osteosarcoma.